The setup going into Elbit Systems' Q2 2026 earnings report is cautiously constructive — a sharp 19% recovery off July lows has carried ESLT to within striking distance of near-term resistance, analyst estimate revisions are running entirely positive (12 upgrades, zero downgrades over the past 30 days), but the stock is pressing against a technical ceiling right as it heads into the print, and the consensus price target sits fractionally below the current price.
The Setup: A Powerful Recovery Into Resistance
ESLT closed at $864.26 on August 5, up 1.77% on the session and a remarkable +19.4% above its July 15 intraday low of $723.58. The five-day trend is firmly up (+9.96%), the 20-day trend has recovered strongly (+13.59%), and the stock is forming what the technical pattern scanner identifies as a Converging Wedge with a bullish signal — typically a coiling structure that resolves decisively in the direction of the breakout.
That setup, however, carries an important asterisk: ESLT is sitting just 0.4% below its 20-day resistance at $867.54, which also maps closely to the wedge's upper boundary. The 100-day trend remains in a moderate downtrend (–0.79% over the period), with that longer-term resistance up at $892.86. The stock is above its 20-day simple moving average of $783.88 and its 50-day SMA of $800.03, both of which now represent meaningful support cushions should the report disappoint. The RSI stands at 63.6 — elevated but not yet in overbought territory, giving room for a positive earnings reaction without an immediately overheated read.
Providing additional context for the move, reports emerged earlier this week that Elbit Systems has held discussions with the UAE regarding a potential military equipment sale valued at over $1 billion — a geopolitical catalyst that could expand the company's addressable market beyond its traditional customer base.
What the Options Market Says
Options flow carries a score of 71/100, which places it in neutral-to-bullish territory, with a MACD signal that has flipped bullish. The overall options confidence classification is NEUTRAL_BULLISH, though confidence is flagged as low given thin liquidity — ESLT is a lower-volume name on U.S. options markets.
The dealer positioning picture shows a call wall at $900 (61 contracts of open interest) and a put wall at $730 (82 contracts), creating a corridor of $730–$900 that is likely to contain the stock's reaction around the earnings event. The gamma bias is rated bullish. Pre-earnings positioning shows notable call building at the $1,100 strike, suggesting at least some market participants are positioned for an outsized upside move — though open interest at that level is limited, and it should be read as speculative positioning rather than a high-conviction institutional bet.
IV rank data is unavailable for ESLT, which makes it difficult to assess whether options premium is elevated heading into the print. With thin options liquidity and a put wall as far down as $730 — roughly 15.5% below current price — the downside corridor in a miss scenario is wide. Traders using options to play the report should be aware that wide bid-ask spreads may make defined-risk structures costly to execute efficiently.
Fundamentals & Estimates: Analysts Raising Numbers
The fundamental picture is solid for a defense contractor in the current environment. Elbit carries a forward P/E of 9.7x — a notably low multiple that reflects both the company's Israeli-domicile discount and the market's traditional reluctance to apply premium multiples to defense names. Revenue is growing at 15.5% year-over-year, return on equity is a healthy 15.6%, and the net profit margin stands at 7.1%.
For the current quarter (Q2 2026), the analyst consensus calls for:
- EPS of $3.68 (range: $3.44–$3.93), implying roughly +14% year-over-year growth versus $3.23 a year ago
- Revenue of $2.23 billion (range: $2.21B–$2.25B), up approximately 13% year-over-year
Looking further out, the full-year 2026 consensus EPS estimate sits at $15.59 (+22% growth), with 2027 estimates at $18.06 (+16%). Revenue is expected to reach $9.07 billion in 2026 and $10.25 billion in 2027. Critically, estimate revision momentum is strongly positive: over the past 30 days, analysts have registered 12 upward EPS revisions and zero downward revisions — a clean sweep that signals growing institutional conviction in Elbit's earnings trajectory. The current-year EPS estimate of $15.59 is also up from $15.08 three months ago, confirming the upward drift is real and sustained.
The one valuation wrinkle: the consensus mean price target is $846.33, sitting 2.1% below the current price of $864.26. The median target of $862.50 is closer to flat. With ratings split at 1 Buy and 5 Hold and a high target of $1,075, the street is not yet aggressively bullish — meaning a strong beat-and-raise could be the catalyst that drives meaningful target upgrades.
Key Levels to Watch
| Level | Price | Significance |
|---|---|---|
| Call Wall / Near-Term Resistance | $900.00 | Dealer gamma concentration; first upside magnet on a beat |
| 100-Day Resistance | $892.86 | Longer-term downtrend ceiling; a close above confirms trend reversal |
| 20-Day Resistance / Wedge Top | $867.54 | Immediate ceiling; already being tested pre-earnings |
| Current Price | $864.26 | As of August 5 close |
| 50-Day SMA | $800.03 | Key dynamic support on any pullback |
| 20-Day Support / Wedge Base | $773.11 | Critical swing support; loss of this level signals trend failure |
| Put Wall | $730.00 | Dealer put concentration; downside anchor in a miss scenario |
Bottom Line
Elbit Systems heads into its Q2 2026 report with favorable estimate momentum, a low-multiple valuation relative to growth, and a strong price recovery that has rebuilt nearly all the ground lost in July's selloff. The converging wedge formation suggests the stock is coiling for a directional move, and earnings will almost certainly be the trigger. A clean beat of the $3.68 EPS consensus paired with guidance at or above the $9.07 billion full-year revenue target — and ideally commentary on the reported UAE sales discussions — could be the catalyst to push through $867 resistance and test the $892–$900 corridor.
If results disappoint or management fails to raise full-year guidance meaningfully, the stock faces a technically precarious position: it has rallied nearly 20% in three weeks and is pressing against resistance. A rejection at $867 on a miss could quickly see the stock retrace toward the $800 SMA and potentially retest the $773 support zone. The wide put wall at $730 defines the floor in a more severe scenario, but that would represent a painful 15.5% drawdown from current levels.
The bull case hinges on whether management raises full-year guidance to reflect the accelerating defense spending cycle and emerging opportunities in new geographies. With 12 consecutive upward EPS revisions over the past 30 days and a forward P/E of just 9.7x on 22% expected earnings growth, the fundamental case for Elbit is compelling — but at $864 with the consensus target at $846, the stock needs the report to do the heavy lifting. If it holds above $867 post-earnings, the path to the $900 call wall opens up meaningfully.
This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.